Cargando…
Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)
OBJECTIVE: VOLUME is a randomized, open-label, post-approval pragmatic trial aiming to evaluate long-term pulmonary and cardiovascular safety of Exubera® (EXU; insulin human [rDNA origin] Inhalation Powder) in routine clinical practice. The primary study objective is to compare risk of persistent de...
Autores principales: | Gatto, Nicolle M., Bracken, Michael B., Kolitsopoulos, Francesca, Duggan, William T., Koch, Gary G., Wise, Robert A., Jackson, Neville C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251384/ https://www.ncbi.nlm.nih.gov/pubmed/32478195 http://dx.doi.org/10.1016/j.conctc.2019.100427 |
Ejemplares similares
-
Implications of product withdrawal on a post-approval pragmatic trial: The VOLUME study experience
por: Kolitsopoulos, Francesca M., et al.
Publicado: (2019) -
Inhaled human insulin (Exubera®): clinical profile and patient considerations
por: Barnett, Anthony H, et al.
Publicado: (2007) -
Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes
por: Profit, Louise
Publicado: (2005) -
Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2008) -
Will availability of inhaled human insulin (Exubera(®)) improve management of type 2 diabetes? The design of the Real World trial
por: Freemantle, Nick, et al.
Publicado: (2006)